戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1  underwent lobectomy (thoracotomy, n = 8439; VATS, n = 4531) and met inclusion criteria.
2                                          All VATS procedures represent an indication for OLV.
3 ts undergoing lobectomy with thoracotomy and VATS, respectively (P < 0.0001).
4 l outcome between intrapleural urokinase and VATS for the treatment of childhood empyema.
5        A single pulmonary nodule resected at VATS was more likely to be malignant in patients with kn
6  than 1 cm but smaller than 3 cm resected at VATS were more likely to be malignant.
7  In 254 patients with one nodule resected at VATS, the nodules were malignant in 108 patients with an
8 eduction in mortality among GBV-C coinfected VATS subjects, after adjusting for HAART status, HIV RNA
9 ncer (NSCLC) using a standard definition for VATS lobectomy (one 4- to 8-cm access and two 0.5-cm por
10 of thoracic surgical patients presenting for VATS.
11 cted NSCLC were prospectively registered for VATS lobectomy.
12                       Pathology reports from VATS performed between January 1995 and July 1997 were s
13 y after intervention between the two groups: VATS (median [range], 6 [3-16] d) versus urokinase (6 [4
14                             Minimal invasive VATS is gaining widespread popularity among our surgical
15 e-institution series demonstrated benefit of VATS lobectomy over lobectomy via thoracotomy in poor pu
16 are still lacking documenting the benefit of VATS versus conventional 'thoracotomy'.
17 ed to elucidate the technical feasibility of VATS in early non-small-cell lung cancer (NSCLC) using a
18 undergone lobectomy by either thoracotomy or VATS between 2000 and 2010.
19 drain with intrapleural urokinase or primary VATS.
20 nce was demonstrated in total hospital stay: VATS versus urokinase (8 [4-17] d and 7 [4-25] d) (p = 0
21 titute's Viral Activation Transfusion Study (VATS), a randomized controlled trial of leukoreduced vs
22 ) of these 111 patients underwent successful VATS lobectomies.
23 d safety of video-assisted thoracic surgery (VATS) lobectomy for small lung cancers.
24 ough a video-assisted thoracoscopic surgery (VATS) approach.
25 rimary video-assisted thoracoscopic surgery (VATS) for the treatment of childhood empyema.
26 hether video-assisted thoracoscopic surgery (VATS) lobectomy is beneficial in high-risk pulmonary pat
27  were significantly lower than those for the VATS arm US dollars 11,379 (US dollars 10,146) (p < 0.00
28 tween GBV-C coinfection and mortality in the VATS cohort.
29 re cosmetic and economical advantages to the VATS approach, large randomized controlled trials are st
30 re similar with video-assisted thoracoscopy (VATS) compared with thoracotomy.
31                   A standardized approach to VATS lobectomy as specifically defined with avoidance of
32 rred, none of which were directly related to VATS technique; seven (7.4%) of 95 patients had grade 3
33 more economic treatment option compared with VATS and should be the primary treatment of choice.
34 d pulmonary complications when compared with VATS patients (P = 0.023).
35 ary function after thoracotomy compared with VATS.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。